Main > ONCOLOGY (**) > Breast Cancer>ER+>HER2- *** > Companion DIAG. > Co: USA. G. 21 Genes Activity Exam.

---

Co: USA. G. 21 Genes Activity Exam.'s subsections
(*) USA Launch Year: 2004
Chemotherapy Benefit Prediction
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 22
Patent>UpDate: 2017. 08.15
Recurrence Prediction
TradeMark
TradeMark Web-Site

Co: USA. G. 21 Genes Activity Exam.'s products
This section has no products